, a bio/informatics shared resource is still "open for business" - Visit the CDS website

Mark Denison
Last active: 2/22/2016

  1. Novel poxvirus infection in 2 patients from the United States. Osadebe LU, Manthiram K, McCollum AM, Li Y, Emerson GL, Gallardo-Romero NF, Doty JB, Wilkins K, Zhao H, Drew CP, Metcalfe MG, Goldsmith CS, Muehlenbachs A, Googe PB, Dunn J, Duenckel T, Henderson H, Carroll DS, Zaki SR, Denison MR, Reynolds MG, Damon IK (2015) Clin Infect Dis 60(2): 195-202
    › Primary publication · 25301210 (PubMed) · PMC5854477 (PubMed Central)
  2. Mutations across murine hepatitis virus nsp4 alter virus fitness and membrane modifications. Beachboard DC, Anderson-Daniels JM, Denison MR (2015) J Virol 89(4): 2080-9
    › Primary publication · 25473044 (PubMed) · PMC4338892 (PubMed Central)
  3. Evaluation of candidate vaccine approaches for MERS-CoV. Wang L, Shi W, Joyce MG, Modjarrad K, Zhang Y, Leung K, Lees CR, Zhou T, Yassine HM, Kanekiyo M, Yang ZY, Chen X, Becker MM, Freeman M, Vogel L, Johnson JC, Olinger G, Todd JP, Bagci U, Solomon J, Mollura DJ, Hensley L, Jahrling P, Denison MR, Rao SS, Subbarao K, Kwong PD, Mascola JR, Kong WP, Graham BS (2015) Nat Commun : 7712
    › Primary publication · 26218507 (PubMed) · PMC4525294 (PubMed Central)
  4. Middle East respiratory syndrome coronavirus not detected in children hospitalized with acute respiratory illness in Amman, Jordan, March 2010 to September 2012. Khuri-Bulos N, Payne DC, Lu X, Erdman D, Wang L, Faouri S, Shehabi A, Johnson M, Becker MM, Denison MR, Williams JV, Halasa NB (2014) Clin Microbiol Infect 20(7): 678-82
    › Primary publication · 24313317 (PubMed) · PMC4618562 (PubMed Central)
  5. Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses. Agnihothram S, Gopal R, Yount BL, Donaldson EF, Menachery VD, Graham RL, Scobey TD, Gralinski LE, Denison MR, Zambon M, Baric RS (2014) J Infect Dis 209(7): 995-1006
    › Primary publication · 24253287 (PubMed) · PMC3952667 (PubMed Central)
  6. Coronavirus replicase-reporter fusions provide quantitative analysis of replication and replication complex formation. Freeman MC, Graham RL, Lu X, Peek CT, Denison MR (2014) J Virol 88(10): 5319-27
    › Primary publication · 24623413 (PubMed) · PMC4019139 (PubMed Central)
  7. Coronaviruses induce entry-independent, continuous macropinocytosis. Freeman MC, Peek CT, Becker MM, Smith EC, Denison MR (2014) mBio 5(4): e01340-14
    › Primary publication · 25096879 (PubMed) · PMC4128357 (PubMed Central)
  8. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant. Agnihothram S, Yount BL, Donaldson EF, Huynh J, Menachery VD, Gralinski LE, Graham RL, Becker MM, Tomar S, Scobey TD, Osswald HL, Whitmore A, Gopal R, Ghosh AK, Mesecar A, Zambon M, Heise M, Denison MR, Baric RS (2014) mBio 5(2): e00047-14
    › Primary publication · 24667706 (PubMed) · PMC3977350 (PubMed Central)
  9. Murine hepatitis virus nsp4 N258T mutants are not temperature-sensitive. Beachboard DC, Lu X, Baker SC, Denison MR (2013) Virology 435(2): 210-3
    › Primary publication · 23099203 (PubMed) · PMC3804408 (PubMed Central)
  10. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. Smith EC, Blanc H, Surdel MC, Vignuzzi M, Denison MR (2013) PLoS Pathog 9(8): e1003565
    › Primary publication · 23966862 (PubMed) · PMC3744431 (PubMed Central)